Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MirtaRett: Mirtazapine in Rett Syndrome
NCT07430046Phase 2Recruiting
- Sponsor
- University of Trieste
- Start
- Jul 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mirtazapine in Rett syndrome (RTT), sponsored by University of Trieste. Started Jul 2025; status: recruiting.
02
Drugs
mirtazapine
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on NCT07430046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07430046.